VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 109 filers reported holding VIKING THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $409,037 | -36.3% | 39,597 | 0.0% | 0.10% | -32.4% |
| Q2 2023 | $641,867 | +13.4% | 39,597 | +16.5% | 0.15% | +10.4% |
| Q1 2023 | $565,934 | +85.1% | 33,990 | +4.5% | 0.13% | +81.1% |
| Q4 2022 | $305,726 | +133.4% | 32,524 | 0.0% | 0.07% | +94.7% |
| Q3 2022 | $131,000 | +22.4% | 32,524 | 0.0% | 0.04% | +46.2% |
| Q2 2022 | $107,000 | +55.1% | 32,524 | +41.0% | 0.03% | +85.7% |
| Q1 2022 | $69,000 | -19.8% | 23,074 | +23.5% | 0.01% | -17.6% |
| Q4 2021 | $86,000 | -26.5% | 18,679 | 0.0% | 0.02% | -37.0% |
| Q3 2021 | $117,000 | +4.5% | 18,679 | 0.0% | 0.03% | +8.0% |
| Q2 2021 | $112,000 | +10.9% | 18,679 | +4.5% | 0.02% | -3.8% |
| Q1 2021 | $101,000 | +18.8% | 17,879 | +21.8% | 0.03% | +13.0% |
| Q4 2020 | $85,000 | +2.4% | 14,679 | -1.3% | 0.02% | +4.5% |
| Q3 2020 | $83,000 | – | 14,879 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 622,249 | $10,360,446 | 3.42% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $16,650,000 | 3.27% |
| Ghost Tree Capital, LLC | 600,000 | $9,990,000 | 2.95% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,000 | $6,327,000 | 2.61% |
| Integral Health Asset Management, LLC | 727,100 | $12,106,215 | 2.44% |
| Sio Capital Management, LLC | 250,000 | $4,162,500 | 2.06% |
| Boxer Capital, LLC | 2,000,000 | $33,300 | 1.64% |
| DAFNA Capital Management LLC | 319,155 | $5,313,931 | 1.59% |
| 5AM Venture Management, LLC | 350,000 | $5,827,500 | 1.49% |
| Monashee Investment Management LLC | 300,000 | $4,995,000 | 1.38% |